2025-01-16 IDOPRESS
Introducing Revolutionary Smart Lock Technology Globally,Crafting a Smarter,Safer Future for Your Home
LAS VEGAS,Jan. 15,2025 -- At CES 2025,Philips and Conex Intelligent Technology,the exclusive partnership in smart home industry since 2017,together introduce a series of smart locks,setting new standards for global home security and convenience. These innovations affirm Philips' commitment to safer,smarter homes worldwide.

Philips Easykey Shines at CES 2025,Leading the New Era of Smart Home Security
Philips Smart Locks: Global Reach,Local Fit
DDL902-MVP: Combines palm vein and facial recognition with 360-degree monitoring via three high-resolution cameras.
DDL505: Designed for extreme temperatures with IP66 waterproof and dustproof capabilities.
DDL611: Built for humid,rainy climates,ensuring durability with IP66 protection.
Philips Sync: Allows simultaneous unlocking of multiple doors for added convenience.
DDL801: A design and functionality masterpiece integrating Philips' latest security tech.
Award and Enhancements:
Philips' 5000 Series Palm Vein Recognition Smart Lock won the CES® 2025 Innovation Award as an 'Honoree',now upgraded with video capabilities.
About Shenzhen Conex Intelligent Technology Co.,Ltd.:
As brand license partners of Koninklijke Philips N.V.,Conex offers innovative smart home solutions in the smart lock and home security domains. Backed by exceptional customer service,Conex ensures seamless consumer experiences,delivering products that redefine home safety.
Experience Philips at CES:
Visit booth No. 52055 to explore these innovations and their integration into smart home systems.
Contact Us:
Aaron Ma – Public Relations Specialist (Global)Email: publicrelations@cone-x.com
About Philips:
Philips,a leader in health technology,focuses on improving well-being through innovation. Based in the Netherlands,it excels in consumer products and healthcare solutions. News at www.philips.com/newscenter.
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map